Table 1. Patient baseline characteristics (N=47).
| Characteristics | N | % | Arm A | Arm B |
|---|---|---|---|---|
| Sex | ||||
| Male | 29 | 61.7 | 14 | 15 |
| Female | 18 | 38.3 | 9 | 9 |
| Median age | 60 | 62 | 58 | |
| Location of primary tumor | ||||
| Colon | 30 | 63.8 | 15 | 15 |
| Rectum | 9 | 19.1 | 3 | 6 |
| Rectosigmoid | 8 | 17.0 | 5 | 3 |
| Prior therapy | ||||
| Surgery | 37 | 78.7 | 18 | 19 |
| Prior >2 lines of chemotherapy | 36 | 76.6 | 18 | 18 |
| Radiotherapy | 9 | 19.1 | 3 | 6 |
| Bevacizumab | 45 | 95.8 | 23 | 22 |
| K-ras status | ||||
| Mutated | 24 | 51.1 | 14 | 10 |
| Wild type | 22 | 46.8 | 8 | 14 |
| Unknown | 1 | 2.1 | 1 | – |
| Metastatic site | ||||
| Lung only | 5 | 10.6 | 1 | 4 |
| Liver only | 4 | 8.5 | 3 | 1 |
| Multiple (peritoneum, adrenal, abdominal LN, chest LN, bone, brain, stomach, etc.) | 38 | 80.9 | 19 | 19 |
LN, lymph nodes.